...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease.
【24h】

DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease.

机译:对活体肾脏供体进行常染色体显性多囊肾疾病风险的DNA检测。

获取原文
获取原文并翻译 | 示例

摘要

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by age-dependent growth of kidney cysts with end-stage renal disease developing in approximately 50% of affected individuals. Living donors from ADPKD families are at risk for developing ADPKD and may be excluded from renal donation if the diagnosis cannot be conclusively ruled out. Radiographic imaging may be adequate to screen for kidney cysts in most at-risk donors but may fail to identify affected individuals younger than 40 years or older individuals from families with mild disease. In this article, we report a strategy that incorporates genetic testing in the evaluation of live kidney donors at risk for ADPKD whose disease status cannot be established with certainty on the basis of imaging studies alone. We show that DNA diagnostics can be used to enhance safe donation for certain living donor candidates at risk for ADPKD.
机译:常染色体显性遗传性多囊性肾病(ADPKD)的特征在于肾脏囊肿的年龄依赖性生长,在约50%的受累个体中发展为终末期肾病。来自ADPKD家庭的活体供体有发展成ADPKD的风险,如果不能最终排除诊断,则可以将其排除在肾脏捐赠之外。放射线照相成像可能足以筛查大多数高危捐献者的肾囊肿,但可能无法从轻度疾病家庭中识别出40岁以下的受影响个体或年龄较大的个体。在本文中,我们报告了一种策略,该策略将基因测试纳入评估有ADPKD风险的活体肾脏供体的评估中,而仅根据影像学研究不能确定其疾病状态。我们表明,DNA诊断可用于增强某些有ADPKD风险的活体供体候选人的安全捐赠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号